Loading…
CIK 0001281446 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("great-point-partners-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| AMYLYX PHARMACEUTICALS INC | COM | $21.1M | 6.9%Prev: 9.5% | 1,750,000 SH | Decreased+50,000 SH |
| APOGEE THERAPEUTICS INC | COM | $28.2M | 9.2%Prev: 5.0% | 374,000 SH | Increased+70,000 SH |
| AVALO THERAPEUTICS INC | COM NEW | $2.3M | 0.7% | 124,666 SH | New |
| CLIMB BIO INC | COM | $3.9M | 1.3% | 979,534 SH | New |
| CONTEXT THERAPEUTICS INC | COM | $6.9M | 2.2%Prev: 1.9% | 4,683,711 SH | Increased |
| CONTINEUM THERAPEUTICS INC | CL A | $9.1M | 3.0% | 800,000 SH | New |
| CULLINAN THERAPEUTICS INC | COM | $6.6M | 2.1% | 634,032 SH | New |
| DIANTHUS THERAPEUTICS INC | COM | $14.4M | 4.7%Prev: 4.3% | 350,000 SH | Increased+84,197 SH |
| DISC MEDICINE INC | COM | $19.9M | 6.4% | 250,000 SH | New |
| EUPRAXIA PHARMACEUTICALS INC | COM | $9.1M | 2.9%Prev: 2.9% | 1,200,000 SH | Increased |
| EVOMMUNE INC | COM SHS | $5.6M | 1.8% | 325,000 SH | New |
| FULCRUM THERAPEUTICS INC | COM | $9.0M | 2.9% | 800,000 SH | New |
| IMMUNOVANT INC | COM | $19.1M | 6.2%Prev: 3.3% | 750,000 SH | Increased+250,000 SH |
| JADE BIOSCIENCES INC | COM NEW | $12.4M | 4.0% | 806,273 SH | New |
| KALVISTA PHARMACEUTICALS INC | COM | $11.1M | 3.6% | 685,632 SH | New |
| NEKTAR THERAPEUTICS | COM NEW | $8.9M | 2.9% | 210,732 SH | New |
| NEUROGENE INC | COM | $7.2M | 2.3%Prev: 3.2% | 350,000 SH | Decreased-96,814 SH |
| ORUKA THERAPEUTICS INC | COM | $5.6M | 1.8%Prev: 1.5% | 183,330 SH | Increased |
| PHARVARIS N V | COM | $2.3M | 0.7%Prev: 1.6% | 82,800 SH | Decreased-72,305 SH |
| RAPT THERAPEUTICS INC | COM NEW | $19.7M | 6.4% | 581,187 SH | New |
| REZOLUTE INC | COM NEW | $2.2M | 0.7% | 951,809 SH | New |
| SANA BIOTECHNOLOGY INC | COM | $2.8M | 0.9%Prev: 1.0% | 700,000 SH | Increased |
| SILENCE THERAPEUTICS PLC | ADS | $4.9M | 1.6% | 808,032 SH | New |
| SOLENO THERAPEUTICS INC | COM | $18.5M | 6.0%Prev: 6.3% | 400,000 SH | Increased+175,000 SH |
| ULTRAGENYX PHARMACEUTICAL IN | COM | $6.9M | 2.2% | 300,000 SH | New |
| UNICYCIVE THERAPEUTICS INC | COM NEW | $4.6M | 1.5% | 796,558 SH | New |
| UPSTREAM BIO INC | COM | $8.1M | 2.6%Prev: 2.3% | 300,000 SH | Increased |
| VOR BIOPHARMA INC | COM NEW | $17.9M | 5.8% | 1,370,107 SH | New |
| ZURA BIO LTD | CLASS A ORD SHS | $20.0M | 6.5% | 3,815,930 SH | New |
| 13F-HR |
| 0001172661-26-003750 |
| $529.1M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001172661-25-003478 | $153.8M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001172661-26-002272 | $435.1M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001172661-25-002331 | $188.8M | View |